Capillary electrophoresis for biopharma drug development
Capillary electrophoresis for biopharma drug development
Capillary electrophoresis (CE) on the PA 800 Plus system enables ultra-high quality separation day in and day out for the development of proteins and next generation therapeutics.
Achieve a better understanding of protein purity, nucleic acid purity and integrity, protein charge heterogeneity, capsid protein purity, and glycan distribution. Overcome the challenges of an ever-changing pipeline with a single platform designed to minimize method development and maximize innovation.
The assessment of your biopharmaceutical deserves the trusted expertise of SCIEX CE.
Flexibility
Gain valuable insights into quality attributes of biotherapeutics with kit-based assays and customizable features to address the evolving drug development pipeline.
Quality
Achieve the resolution and reproducibility you need using industry and regulatory trusted technology, and meet data management needs with platform compatibility.
Portability
Develop and lock down methods applicable to QC or regulated environments. Easily transfer methods between instruments or sites using robust kit-based workflows with proven portability.
Nail consistent outcomes
Even the slightest temperature variations can throw off your results. Exclusive recirculating liquid coolant enables the precise control of separation temperature in the capillary.
Flexibility is everything.
Ensure consistent, reproducible results with precise control. Get top-notch resolution with electrokinetic injection, tackle sample ionic strength with hydrodynamic injection, and master sensitivity with field-amplified sample stacking.
When more than just speed matters.
Strike the perfect balance between resolution and analysis time. Harness up to 30 kV separation voltage to tailor for your workflow and sample needs.
Cut out the noise and irrelevant targets.
Boost the signal-to-noise ratio for specific analytes and ensure spot-on, reliable results by adjusting a wide range of detection wavelengths.
Switch up the size to boost separation.
Enhance selectivity for specific analytes and achieve superior resolution by adjusting the capillary length and choosing the right capillary coating.
Not everything is easy to spot.
Achieve high sensitivity or detect lower concentrations by switching between UV and LIF detectors based on your needs.
Monoclonal antibody and complex protein applications
Cell and gene therapy applications
Determine the apparent molecular weight of proteins to evaluate the size heterogeneity, purity and manufacturing consistency of biologics with capillary electrophoresis-sodium dodecyl sulfate (CE-SDS).
Obtain automated, quantitative purity data on both intact and reduced mAbs with speed and accuracy.
Analysis of both reduced (top) and non-reduced (bottom) IgG suitability standard.
Peak identification: 1: Internal standard (10 kDa); 2: Light chain (L); 3: Non-glycosylated (NG) Heavy chain (H); 4: Heavy chain (H); 6: Heavy chain (2H); 7: 2 heavy 1 light chain (2H1L); 8: NG HC; 9: IgG monomer.
Capillary zone electrophoresis (CZE) combines the benefits of native state analysis with the speed and resolution expected of a capillary electrophoresis method. CZE can be easily applied to therapeutic proteins such as antibody-drug conjugates (ADCs), pre-clinical monoclonal antibodies (mAbs), and fusion proteins with little to no method development.
Simply dilute, shoot and prepare for your next CE application.
Full view and zoomed electropherogram of trastuzumab.
Establish the identity and stability of the molecule with accurate determination of a protein’s charge heterogeneity using capillary isoelectric focusing (cIEF).
cIEF separation of different commercial lots under identical separation conditions.
The fast glycan labeling and analysis kit delivers rapid glycan heterogeneity identification. Combine simplified sample preparation, rapid separations, and automated glycan identification to make confident decisions quickly.
Ultrafast high resolution CE analysis of PNGase F released and fluorophore labeled IgG N-glycans using the HR-NCHO gel buffer.
RNA integrity and quality analysis is critical to ensuring the efficacy of RNA-based therapeutics and vaccines. Designed for the separation of single-stranded oligonucleotides from 50-9,000 nucleotides and beyond.
Electropherogram of mRNA extracted from an LNP.
Understanding product stability lays the foundation for improved drugs. Give your team the power to determine the lengths of the adenosine tails and their distribution profiles in mature mRNA products with the ssDNA 100-R kit.
Poly[A] tail analysis from mRNA with CGE-UV. Electropherogram shows single-base resolution of mRNA poly[A] tails with most abundant species of 121 nt in length.
The quality of pDNA is crucial for high-efficiency manufacturing of proteins, viral vectors, and in vitro transcribed RNA (IVT RNA). Determine linearization efficiency with excellent separation for different topological variants of pDNA.
Linearized plasmid purity analysis and size estimation of a 7.9kb plasmid sample. The electropherogram shows the sample prior to linearization, containing mainly the supercoiled isoform and after linearization.
Viral vector characterization for vaccine and therapeutic drug development includes assessing the viral proteins. While information on purity and protein ratios can be obtained with liquid chromatography-based methods, an orthogonal approach with CE is advantageous to avoid missing VP’ forms. Avoid lengthy assay adjustments with a kit-based protein profiling workflow suitable across serotypes and viral vectors.
Separation of VP proteins from different AAV serotypes. Excellent resolution of VP proteins labelled with fluorescence dye was acheived with CE-SDS-LIF.
The integrity and purity of the viral genome are CQAs that impact vector potency, immunogenicity and transduction efficiency. Simplify viral vector genome analysis with a workflow suitable across serotypes and viral vectors.
High-resolution genome integrity analysis of AAV8 with CGE and LIF detection. The intact genome of 2.4kb was well separated from potential partial genomes and host cell RNA and DNA impurities.
Determine multiple CQAs, including full-and-empty ratios, on one platform.
Standard curves for full-and-empty capsid determination. Left: AAV genome titer determination with CGE. The linear dynamic range (LDR) was determined from 2.56x1010 GC/mL-2.62x1013 GC/mL with R² = 0.9967. Right: AAV capsid titer determination with LDR from 6.41x109 GC/mL-2.62x1013 GC/mL with R2 = 0.9973.
Determine pDNA fragment sizes across a wide range.
Separation of topological isoforms of 5 plasmids (2.7–18.9 kb) using the DNA 20 kb Plasmid and Linear kit.
Assess residual nucleic acid sizes and quantities simultaneously.
Electropherogram showing baseline separation of a linear dsDNA ladder from 100-15,000 bp.
Overlay of electropherograms from a mixture of sgRNA and Cas9 mRNA and an RNA ladder using the BioPhase 8800 system. The mRNA of ~4500 nt and the sgRNA of 100 nt can be assessed within the same analysis (green trace). The RNA ladder is shown in blue.
Achieve superior resolution and repeatability for purity assessments of intermediate products.
CGE analysis of pegRNA (blue trace) and noncomplementary RNA standard (STD, green trace) with similar length. Left: Before method optimization, the pegRNA (blue trace) shows extensive tailing compared to the noncomplementary STD (green trace). Right: After method optimization, the pegRNA sample shows a single sharp peak with comparable peak width as the non-complementary STD.
Assess linear DNA sizes and purity confidently with ultra-high resolution over a wide size range.
Linearized plasmid purity analysis and size estimation of a 7.9 kb plasmid sample. The electropherogram shows the sample prior to linearization, containing mainly the supercoiled isoform and after linearization.
“A sensitive, analytical method for quantitative estimation of product-related impurities such as nonglycosylated molecules, half antibodies, and fragments.” - USP referenced USP 39 NF 34 Chapter
Develop and lock down methods applicable to QC or regulated environments. The PA 800 Plus system easily transfers methods using robust, automated assays with proven portability—perfect for global multi-user, multi-instrument organizations
CE systems from SCIEX have earned a global reputation for consistently meeting or exceeding our customers’ quality expectations. Our commitment to excellence and continuous improvement is reflected in our comprehensive quality management system, which complies with the requirements of ISO 9001:2008.
Meet data management needs with direct control. Confidently safeguard the success of your biologics with a system that enables regulatory compliance.
Reduce regulatory risk and maximize method transfer efficiency. Enable advanced integration of your PA 800 Plus system with the Empower Chromatography Data System using the PA 800 Plus driver for Empower software.
Boost your laboratory's productivity by seamlessly integrating it into a single software solution. Take control of your PA 800 Plus system with the Thermo Scientific™ Chromeleon™ driver and unleash next-level performance with powerful processing, customizable reporting, and robust compliant tools.
Experience unparalleled accuracy and efficiency in your capillary electrophoresis analysis with SCIEX 32 Karat software, the ultimate single-point controller for the PA 800 Plus system. It includes all current, tested methods for the PA 800 Plus system, covering IgG, CHO, cIEF, SDS MW, Fast Glycan, RNA, and performance applications.
Reclaim time for innovation by identifying and advancing drug candidates more confidently with analytical strategies that support your team across modalities, from discovery to commercialization.
Break through barriers and extend the frontiers of mRNA, saRNA, and circRNA development with intuitive analytical solutions. Confidently innovate with high-quality, sensitive, and accurate data to assess integrity, purity, and CQAs.
Advance your projects with purpose-built solutions for the analysis of pDNA and dsDNA to support the development of your mRN), viral vectors, recombinant proteins, and other new modalities.
Optimize your processes with solutions that overcome the analytical challenges of viral vector-based drugs. Take control of full and empty ratios and protein and genome profiles. Break down the boundaries of protein and post-translational modification (PTM) characterization with dedicated high-resolution workflows offering unprecedented depth.
Set your own schedule for CRISPR/Cas9 gene editing with innovative, intuitive analytical solutions. Unleash the potential of your Cas9 mRNa, sgRNA, and Cas9 proteins by understanding quality, purity, and safety and assessing on/off target effects.
Set the pace with confidence. Cell line monitoring and analysis solutions verify the identity, purity, and stability of lead candidates with high throughput strategies that are ready for automation.
Fully understand drug candidate glycoprofiles with pipeline-specific solutions. Gather critical high-resolution information and site-specific data points with advanced glycan analysis for complex biologic development.
Pursue the end goal with confidence. Achieve the full picture and accelerate decisions with comprehensive characterization of biopharmaceutical charge variants.
Stay up-to-date with biopharma conversations on LinkedIn